Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023October 3, 2023 Bod Science is plotting a capital raise and investigating new revenue streams as it reassured the […]
Emyria shares take a hit as company raises another A$2.5 million by Steve Jones May 1, 2023May 1, 2023
Emyria eyes US market with launch of high-dose CBD capsule by Steve Jones April 24, 2023April 24, 2023
